ArticleCureus2025
Pituitary Gland Metastases As the Initial Presentation of Lung Adenocarcinoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pituitary gland metastases (PMs) are rare and typically asymptomatic, often discovered incidentally in patients with known malignancies. Symptomatic PMs as the initial presentation of cancer are uncommon. We report a case of a 52-year-old woman with no prior oncologic history who presented with progressive unilateral vision loss, headaches, and systemic symptoms. Imaging revealed a sellar and suprasellar mass, and endocrine evaluation indicated both anterior and posterior pituitary dysfunction. Surgical resection and histopathological analysis confirmed metastatic adenocarcinoma of the lung. The patient was treated with radiation to the sellar region and systemic chemoimmunotherapy, resulting in radiologic improvement and partial improvement in vision four months after the initiation of treatment. This case underscores the importance of considering metastatic disease in the differential diagnosis of pituitary masses, particularly in patients with acute neuro-ophthalmologic and endocrine abnormalities. Though difficult to distinguish clinically and radiologically from primary sellar tumors, the presence of diabetes insipidus may indicate a PM diagnosis given its rarity in pituitary adenoma cases. Early recognition and multidisciplinary intervention are critical to improving outcomes and preserving function in such rare and complex presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.